Page 71 - 2021_03-Haematologica-web

Impact of GC reaction on self-/polyreactivity in PCNSL
Deutsche Krebshilfe (Grant 70112052) (to MD), the Köln Project (to HBPP) (to CM), PURE and OsteoSys (EFRE Fortune Program (Grant 2680138201) (to MMR), the Medical 080041) (to CM), de.NBI, (FKZ 031 A 534A) (to CM) as well Faculty at RUB (FoRUM) (CM), the HUPO Brain Proteome as Eranet Neuron Silence (FS 4108270133) (to CM).
References
1.Deckert M, Paulus W, Kluin P, Ferry J. Lymphomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. Who classi- fication of tumours of the central nervous system Revised 4th edition ed. Lyon: IARC, 2016:272-277.
2. Montesinos-Rongen M, Küppers R, Schlüter D, et al. Primary central nervous system lymphomas are derived from germinal-cen- ter B cells and show a preferential usage of the v4-34 gene segment. Am J Pathol. 1999; 155(6):2077-2086.
3. Thompsett AR, Ellison DW, Stevenson FK, Zhu D. V(h) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activ- ity. Blood. 1999;94(5):1738-1746.
4. Montesinos-Rongen M, Purschke F, Küppers R, Deckert M. Immunoglobulin repertoire of primary lymphomas of the central nervous system. J Neuropathol Exp Neurol. 2014; 73(12):1116-1125.
5. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary pro- gressive multiple sclerosis. Brain Pathol. 2004;14(2):164-174.
6. Roco JA, Mesin L, Binder SC, et al. Class- switch recombination occurs infrequently in germinal centers. Immunity. 2019;51(2):337- 350.e7.
7. Montesinos-Rongen M, Besleaga R, Heinsohn S, et al. Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients. Virchows Arch. 2004;444(5):436-438.
8. Montesinos-Rongen M, Hans VH, Eis- Hübinger AM, et al. Human herpes virus-8 is not associated with primary central nerv- ous system lymphoma in HIV-negative patients. Acta Neuropathol. 2001; 102(5):489-495.
9.Paulus W, Jellinger K, Hallas C, Ott G, Müller-Hermelink HK. Human herpesvirus- 6 and epstein-barr virus genome in primary cerebral lymphomas. Neurology. 1993; 43(8):1591-1593.
10. Montesinos-Rongen M, Purschke FG, Brunn A, et al. Primary central nervous system (cns) lymphoma B cell receptors recognize cns proteins. J Immunol. 2015;195(3):1312- 1319.
11. Lefranc MP, Giudicelli V, Duroux P, et al. Imgt(r), the international immunogenetics information system(r) 25 years on. Nucleic Acids Res. 2015;43(Database issue):D413- 422.
12. Hervé M, Xu K, Ng YS, et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reac- tivity. J Clin Invest. 2005;115(6):1636-1643.
13.Brändle SM, Obermeier B, Senel M, et al. Distinct oligoclonal band antibodies in mul-
tiple sclerosis recognize ubiquitous self-pro- teins. Proc Natl Acad Sci U S A. 2016; 113(28):7864-7869.
14. Hong SH, Cho JG, Yoon KJ, et al. The anti- body atliximab attenuates collagen-induced arthritis by neutralizing aimp1, an inflam- matory cytokine that enhances osteoclasto- genesis. Biomaterials. 2015;44:45-54.
15. Montesinos-Rongen M, Brunn A, Bentink S, et al. Gene expression profiling suggests pri- mary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia. 2008;22(2):400-405.
16. Sachen KL, Strohman MJ, Singletary J, et al. Self-antigen recognition by follicular lym- phoma B-cell receptors. Blood. 2012; 120(20):4182-4190.
17. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003; 301(5638):1374-1377.
18. Iype J, Datta M, Khadour A, et al. Differences in self-recognition between secreted antibody and membrane-bound B cell antigen receptor. J Immunol. 2019; 202(5):1417-1427.
19. Torres M, May R, Scharff MD, Casadevall A. Variable-region-identical antibodies dif- fering in isotype demonstrate differences in fine specificity and idiotype. J Immunol. 2005;174(4):2132-2142.
20. Tudor D, Yu H, Maupetit J, et al. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-hiv-1 human broadly neutralizing 2f5 antibody. Proc Natl Acad Sci U S A. 2012;109(31):12680-12685.
21. Spies E, Fichtner M, Müller F, et al. Comment on "primary central nervous sys- tem (cns) lymphoma B cell receptors recog- nize cns proteins". J Immunol. 2015; 195(10):4549-4550.
22. Cha SC, Qin H, Kannan S, et al. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J Immunol. 2013;190(9):4887-4898.
23. Sutton LA, Agathangelidis A, Belessi C, et al. Antigen selection in B-cell lymphomas - tracing the evidence. Semin Cancer Biol. 2013;23(6):399-409.
24. Montesinos-Rongen M, Schmitz R, Courts C, et al. Absence of immunoglobulin class switch in primary lymphomas of the central nervous system. Am J Pathol. 2005; 166(6):1773-1779.
Natl Acad Sci U S A. 2014;111(25):E2567-
2575.
28.Tiller T, Tsuiji M, Yurasov S, Velinzon K,
Nussenzweig MC, Wardemann H. Autoreactivity in human igg+ memory B cells. Immunity. 2007;26(2):205-213.
29. Diamond B, Scharff MD. Somatic mutation of the t15 heavy chain gives rise to an anti- body with autoantibody specificity. Proc Natl Acad Sci U S A. 1984;81(18):5841-5844.
30. Seamons A, Perchellet A, Goverman J. Immune tolerance to myelin proteins. Immunol Res. 2003;28(3):201-221.
31.Deckert M, Engert A, Brück W, et al. Modern concepts in the biology, diagnosis, differential diagnosis and treatment of pri- mary central nervous system lymphoma. Leukemia. 2011;25(12):1797-1807.
32. Brierley CK, Steensma DP. Targeting splicing in the treatment of myelodysplastic syn- dromes and other myeloid neoplasms. Curr Hematol Malig Rep. 2016;11(6):408-415.
33. Hardin JA, Mimori T. Autoantibodies to ribonucleoproteins. Clin Rheum Dis. 1985; 11(3):485-505.
34.Lerner MR, Steitz JA. Antibodies to small nuclear rnas complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1979;76(11):5495-5499.
35. McClain MT, Ramsland PA, Kaufman KM, James JA. Anti-sm autoantibodies in sys- temic lupus target highly basic surface struc- tures of complexed spliceosomal autoanti- gens. J Immunol. 2002;168(4):2054-2062.
36. Sanz I, Dang H, Takei M, Talal N, Capra JD. Vh sequence of a human anti-sm autoanti- body. Evidence that autoantibodies can be unmutated copies of germline genes. J Immunol. 1989;142(3):883-887.
37. Deckert M, Brunn A, Montesinos-Rongen M, Terreni MR, Ponzoni M. Primary lym- phoma of the central nervous system--a diagnostic challenge. Hematol Oncol. 2014; 32(2):57-67.
38. Dühren-von Minden M, Übelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012; 489(7415):309-312.
39. Craig VJ, Arnold I, Gerke C, et al. Gastric malt lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood. 2010;115(3):581-591.
40. Seiler T, Woelfle M, Yancopoulos S, et al. Characterization of structurally defined epi- topes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood. 2009;114(17):3615-3624.
41. Zhu D, Bhatt S, Lu X, et al. Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors. Leukemia. 2015;29(7):1587- 1599.
42. Thurner L, Preuss KD, Bewarder M, et al. Hyper-n-glycosylated samd14 and neura- bin-i as driver autoantigens of primary cen- tral nervous system lymphoma. Blood. 2018;132(26):2744-2753.
25.
26.
Cyster JG, Hartley SB, Goodnow CC. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature. 1994; 371(6496):389-395.
Burnett DL, Langley DB, Schofield P, et al. Germinal center antibody mutation trajecto- ries are determined by rapid self/foreign dis- crimination. Science. 2018;360(6385):223- 226.
27.Sabouri Z, Schofield P, Horikawa K, et al. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc
haematologica | 2021; 106(3)
717